News

Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments
Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule ...
Verywell Health on MSN16h
Could Wegovy Cause Hair Loss?
People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...
Devdiscourse2h
Novo Nordisk and Septerna Team Up for Groundbreaking Obesity Treatments
Novo Nordisk partners with U.S. biotech Septerna in a $2.2 billion deal to develop oral small molecule drugs for obesity and ...
Health on MSN15h
Why You Might Tolerate One Weight Loss Drug Better Than Another, According to Experts
Fact checked by Nick Blackmer Tirzepatide and semaglutide, the ingredients in popular weight loss drugs, can both cause side ...
NewsNation on MSN20h
Here are 8 FDA-approved medications for weight loss
As medications become increasingly popular to support weight loss, not all of them are approved by the U.S. Food and Drug Administration. Most prescription weight-loss drugs work by making you feel ...
Newsweek21h
Joe Edwards
Joe Edwards is a Live News Reporter based in Newsweek's London Bureau. He covers topics related to weather, climate, and extreme weather events. Joe joined Newsweek in April 2024 after graduating ...